Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Independent evaluation of the anatomical and behavioral effects of Taxol in rat models of spinal cord injury

Independent evaluation of the anatomical and behavioral effects of Taxol in rat models of spinal cord injury

Exp Neurol, 2014 · DOI: 10.1016/j.expneurol.2014.06.020 · Published: November 1, 2014

Spinal Cord InjuryPharmacologyRegenerative Medicine

Simple Explanation

This study aimed to verify if Taxol, a drug that stabilizes microtubules, could reduce scar tissue formation and improve recovery after spinal cord injury in rats. The researchers found that Taxol did reduce scarring in spinal cord injury models, specifically after dorsal hemisection (DHx) injury. However, Taxol did not improve the growth of nerve fibers or enhance functional recovery in rats with moderate spinal contusion injury.

Study Duration
Phase 1: 7 days; Phase 2: 8 weeks
Participants
Phase 1: 28 female Sprague-Dawley rats; Phase 2: 24 female Sprague-Dawley rats
Evidence Level
Not specified

Key Findings

  • 1
    Taxol significantly reduced scarring at the injury site after dorsal spinal hemisection (DHx).
  • 2
    Taxol did not improve functional recovery after spinal contusion injury.
  • 3
    Taxol did not affect serotonergic axon density below the lesion in the spinal contusion injury model.

Research Summary

This study replicated some, but not all, of the previously reported benefits of Taxol in rat models of spinal cord injury. Taxol was found to reduce fibrotic scarring in both dorsal hemisection (DHx) and spinal contusion injury models. However, Taxol did not improve functional recovery or promote serotonergic axon growth in a spinal contusion injury model, as previously reported.

Practical Implications

Further Research Needed

More basic and preclinical mechanistic studies are needed before moving forward with translation of this anti-cancer drug for repair after SCI.

Targeted Scar Reduction

Taxol may be useful in reducing specific types of scarring after spinal cord injury, potentially creating a more permissive environment for axon regeneration.

Combinatorial Approaches

Combining Taxol with other therapies that promote axon growth and neuronal survival might be necessary to achieve functional improvements after SCI.

Study Limitations

  • 1
    [object Object]
  • 2
    [object Object]
  • 3
    [object Object]

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury